• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Tissue Injury (4559); Swelling/ Edema (4577); Insufficient Information (4580)
Event Date 08/24/2021
Event Type  Injury  
Event Description
Title: outcome analysis of dorsal buccal mucosal graft urethroplasty in perimenopausal women with urethral stricture disease.The purpose of this study is to assess the clinical outcomes following dorsal buccal mucosal graft urethroplasty (bmgu) in perimenopausal women (pmw) suffering from urethral stricture disease.Between march 2014 and march 2020, 8 patients with pmw underwent bmgu.The mean age of the patients is 52.1 years.3-¿0¿chromic catgut (chromic gut® ethicon inc., usa).Was used to close the harvested area for the graft.4-¿0¿ polydioxanone (pds® ethicon inc., usa) sutures were used for the urethroplasty.Urethral site complications (n=5) clitoral edema.(n=4) splaying of urinary stream.(n=1) stricture recurrence.Donor site complications (n=2) restriction of mouth opening.(n=3) oral numbness or pain.(n=1) facial swelling.In conclusion, dorsal bmgu in females for urethral stricture disease offers successful urethral reconstruction and the advantage of least disruption of continence mechanism and resilience to hormonal changes in pmw.
 
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the surgeon believe that any of the ethicon products involved caused and/or contributed to the post-operative complications described in the article? which specific ethicon products have been used during the procedures (product code, lot number)? does the surgeon believe there was any deficiency with any of the ethicon products used in this procedure? if so, please provide details.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Patient demographics? this report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.(b)(4).The single complaint was reported with multiple events.There are no additional details regarding the additional events.Citation: iyyan ab, murugan pp, rajagopal sv, sali sa.Outcome analysis of dorsal buccal.Mucosal graft urethroplasty in perimenopausal women with urethral stricture.Disease.Urol sci 2022;33:26-9.Https://doi.Org/10.4103/uros.Uros_85_21.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT
Type of Device
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key15681327
MDR Text Key302502183
Report Number2210968-2022-08845
Device Sequence Number1
Product Code NEW
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
N18331
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 10/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/27/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received10/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-